Pralidoxime Safety

Pralidoxime Safety is a pharmacological construct that refers to the assessment of the risk-benefit profile and adverse effect potential of pralidoxime therapy within the management of organophosphate poisoning.

26

Publications

827

Citations

100

Authors

41

Institutions

Publications per year

2017–2026

0

Authors

100

  1. NN
    Nicolas Nagelkerke

    United Arab Emirates University, United Arab Emirates

    2 publications · 82 citations

    2

    h-index

  2. MM
    Maria Mercurio‐Zappala

    Washington Poison Center, United States

    2 publications · 38 citations

    2

    h-index

  3. KK
    Kamil Kuča

    University of Hradec Králové, Czechia

    2 publications · 82 citations

    2

    h-index

  4. GP
    Georg Petroianu

    United Arab Emirates University, United Arab Emirates

    2 publications · 82 citations

    2

    h-index

  5. JK
    Jiřı́ Kassa

    Jan Evangelista Purkyně Military Medical Academy, Czechia

    2 publications · 82 citations

    2

    h-index

1–5 of 100

Venues

  1. Human & Experimental Toxicology

    4 publications · 68 citations

    4

    h-index

  2. Journal of Toxicology Clinical Toxicology

    2 publications · 112 citations

    2

    h-index

  3. Journal of Food and Drug Analysis

    1 publications · 42 citations

    1

    h-index

  4. American Journal of Health-System Pharmacy

    AJHP · 1 publications · 11 citations

    1

    h-index

  5. 1

    h-index

1–5